Age-related ocular conditions: Current treatments and role of cyclodextrin-based nanotherapies.
Int J Pharm. 2021 Jun 15;603:120707. doi: 10.1016/j.ijpharm.2021.120707. Epub 2021 May 13.
Int J Pharm. 2021.
PMID: 33991594
Review.